Table 2 Baseline patients characteristics
Baseline (2010.11.01–2011.10.31) | Overall | UEBMI | URBMI |
|---|---|---|---|
No. patients | n = 2971 | n = 1760 | n = 1211 |
Gender | |||
 Female | 1170.0 (39.4) | 736.0 (41.8) | 434.0 (35.8) |
 Male | 1801.0 (60.6) | 1024.0 (58.2) | 777.0 (64.2) |
Age (years) | |||
 Mean ± SD | 50.3 ± 12.7 | 52.4 ± 11.8 | 47.3 ± 13.5 |
Age group | |||
 18 ≤ age < 30 | 187.0 (6.3) | 66.0 (3.8) | 121.0 (10.0) |
 30 ≤ age < 40 | 379.0 (12.8) | 168.0 (9.5) | 211.0 (17.4) |
 40 ≤ age < 50 | 847.0 (28.5) | 445.0 (25.3) | 402.0 (33.2) |
 50 ≤ age < 60 | 887.0 (29.9) | 625.0 (35.5) | 262.0 (21.6) |
 ≥ 60 | 671.0 (22.6) | 456.0 (25.9) | 215.0 (17.8) |
Hospital level | |||
 Primary | 76.0 (2.6) | 45.0 (2.6) | 31.0 (2.6) |
 Secondary | 905.0 (30.5) | 517.0 (29.4) | 388.0 (32.0) |
 Tertiary | 1990.0 (67.0) | 1198.0 (68.1) | 792.0 (65.4) |
Length of stay (days) | |||
 Mean ± SD | 254.7 ± 135.1 | 244.9 ± 137.9 | 268.9 ± 129.8 |
 Days ≤ 100 | 737.0 (24.8) | 482.0 (27.4) | 255.0 (21.1) |
 100 < days ≤ 300 | 501.0 (16.9) | 315.0 (17.9) | 186.0 (15.4) |
 > 300 days | 1733.0 (58.3) | 963.0 (54.7) | 770.0 (63.6) |
Follow-up no. patients | |||
 First year (2011.11.01–2012.10.31) | 2021 | 1145 | 876 |
 Second year (2012.11.01–2013.10.31) | 1901 | 1079 | 822 |
 Third year (2013.11.01–2014.10.31) | 1754 | 988 | 766 |